AZ-17

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameAZ-17

Drug Alias NameAZ-17

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Interleukin-6Anti-Interleukin-23

TargetsInterleukin-6Interleukin-23

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAllozyne

China Registration ClassN/A

Develop Information

Active CompaniesAllozyne

Inactive CompaniesN/A

Active IndicationsPsoriasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A